In a time of increasingly individualized healthcare, Elizabeth Philp has emerged as a significant figure of innovation, particularly in the fast-evolving field of compounded pharmacy. As the co-founder and CEO of Roseway Labs, Philp is at the forefront of a drive to make bespoke medications more available, disrupting the standard one-size-fits-all